10-K/A

BIOTIME, INC 10K/A 12-31-2014

Company: Lineage Cell Therapeutics, Inc.
Filed: April 29, 2015
Period of Report: December 31, 2014
Accession Number: 0001140361-15-016814

View Document ↗ View on SEC.gov ↗